News that the U.S. Department of Justice is going to court to block Anthem's efforts to acquire Cigna Corp. and Aetna's effort to acquire Humana raises an important question: How much cash could the acquisition targets get if the deals die?
Indianapolis-based Anthem has been trying to acquire Bloomfield, Connecticut-based Cigna for about $48 billion in cash and stock. Hartford-based Aetna agreed to pay about $37 billion in cash and stock for Louisville, Kentucky-based Humana.
Like most publicly traded companies involved in major deals, negotiators included provisions for what might happen if the deals collapsed in both the Anthem-Cigna merger agreement and the Aetna-Humana agreement.
Recommended For You
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Allison Bell
Allison Bell, a senior reporter at ThinkAdvisor and BenefitsPRO, previously was an associate editor at National Underwriter Life & Health. She has a bachelor's degree in economics from Washington University in St. Louis and a master's degree in journalism from the Medill School of Journalism at Northwestern University. She can be reached through X at @Think_Allison.
